Fenofibric Acid Capsule, Delayed Release
Product Images NDC 0115-1325

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 0115-1325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 (Fenofibric Acid Delayed Release Capsules 1)

FDA Label Image

1 (Fenofibric Acid Delayed Release Capsules 2)

This text provides details about a medication named Fenofibric Acid in delayed-release capsules form. It includes information about the active ingredient, dosage, storage instructions, manufacturer, and distributor. The medication is indicated for prescription use only.*

FDA Label Image

2 (Fenofibric Acid Delayed Release Capsules 3)

This is a description of Fenofibric Acid Delayed-Release Capsules with a strength of 135 mg. The capsules are packaged in a bottle containing 90 capsules each and are prescription-only medication. The usual dosage information can be found in the package insert. The medication should be stored at a temperature of 20° to 25°C and protected from moisture. The manufacturing information provided includes details about Amneal Pharmaceuticals in India and the USA. Lastly, the medication should be dispensed in a tightly-closed container with a child-resistant closure.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.